Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spleen aminopeptide oral lyophilized powder for prevention of acute exacerbations in bronchiectasis
ChiCTR2300069002Phase 2Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Aug 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchiectasis comparing SAOLP group with Placebo group (2 arms). Primary endpoint: Percentage of participants with acute exacerbations. Started Aug 2017; status: completed.
02
Drugs
spleen polypeptide
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ChiCTR2300069002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069002.